Biogen 1st qtr profit jumps 71 pct as MS drug Tecfidera shines
April 24, 2015 at 07:07 AM EDT
April 24 (Reuters) - Biogen Inc reported a 71 percent rise in quarterly profit, driven by strong demand for its top-selling oral multiple sclerosis (MS) drug, Tecfidera.
